EQUITY ISSUE
![Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details](https://img.etimg.com/thumb/msid-111483559,width-100,height-75,resizemode-4/markets/ipos/fpos/emcure-pharmaceuticals-ipo-booked-nearly-3x-so-far-on-day-2-check-gmp-and-other-details.jpg)
Emcure Pharmaceuticals IPO booked nearly 5x so far on Day 2. Check GMP and other details
Emcure Pharmaceuticals' IPO has been oversubscribed nearly three times as of Thursday, the second day of bidding. The bidding concludes on July 5. The categories reserved for NII and retail investors were subscribed the most at 13 times and 3.43 times, respectively.
![Bansal Wire IPO booked 5.72 times on Day 2. Check GMP and other details](https://img.etimg.com/thumb/msid-111483730,width-100,height-75,resizemode-4/markets/ipos/fpos/bansal-wire-ipo-booked-nearly-4-times-on-day-2-check-gmp-and-other-details.jpg)
Bansal Wire IPO booked 5.72 times on Day 2. Check GMP and other details
Bansal Wire's IPO has been nearly 4 times oversubscribed on its second day, fueled by robust demand from non-institutional and retail investors. The IPO, conducted through the book-building method, reserves 50% for qualified institutional buyers, 35% for retail investors, and 15% for non-institutional investors.
![Bansal Wire IPO: Should you subscribe to the Rs 745 cr-issue?](https://img.etimg.com/thumb/msid-111447315,width-100,height-75,resizemode-4/markets/ipos/fpos/bansal-wire-ipo-should-you-subscribe-to-the-rs-745-cr-issue.jpg)
Bansal Wire IPO: Should you subscribe to the Rs 745 cr-issue?
Bansal Wire IPO: Bansal Wire's IPO offers 2.19 crore shares, closing on July 5. Analysts recommend high-risk investors consider the IPO at a P/E ratio of 41.41x. The company plans to use funds for debt repayment, with a price band of Rs 243-256 per share.
![Bansal Wire IPO offers exposure to domestic manufacturing opportunity](https://img.etimg.com/thumb/msid-111426861,width-100,height-75,resizemode-4/markets/ipos/fpos/bansal-wire-offers-exposure-to-domestic-manufacturing-opportunity.jpg)
Bansal Wire IPO offers exposure to domestic manufacturing opportunity
Bansal Wire Industries plans to raise Rs 745 crore through an IPO to reduce debt and meet working capital needs. The company doubled its installed capacity with a Rs 500 crore investment, expecting full benefits this fiscal year. Additionally, the IPO will reduce long-term debt by two-thirds, leading to lower interest expenses. Bansal Wire Industries' EBITDA margin expanded to 6% in FY24, with RoE and RoCE above industry averages.
![Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issue](https://img.etimg.com/thumb/msid-111400321,width-100,height-75,resizemode-4/markets/ipos/fpos/emcure-pharmaceuticals-ipo-10-things-to-know-before-subscribing-to-the-issue.jpg)
Emcure Pharmaceuticals IPO: 10 things to know before subscribing to the issue
Emcure Pharmaceuticals IPO is scheduled to open for subscription on July 3 and will close on July 5. The company aims to raise approximately Rs 1,952 crore through the public offer. Market analysts indicate that the current GMP of the pharma company stands at Rs 260 in the unlisted market.
![Fresh capital raised via IPOs surges to a 9-year high, hints at private capex revival](https://img.etimg.com/thumb/msid-111390174,width-100,height-75,resizemode-4/markets/ipos/fpos/fresh-capital-raised-via-ipos-surges-to-a-9-year-high-hints-at-private-capex-revival.jpg)
Fresh capital raised via IPOs surges to a 9-year high, hints at private capex revival
Of the ₹33,610 crore raised by 37 companies so far in 2024, about 45%, or ₹15,190 crore, were through new shares, the highest proportion since 2015, when India Inc. raised nearly 48% fresh capital, according to data from primedatabase.com. The funds raised as fresh issues in 2024 were to either finance capital assets or retire existing debt obtained to build capacities, according to IPO documents.
Vraj Iron and Steel IPO picks up pace on Day 2. Check subscription, GMP and other details
The initial public offer (IPO) of Vraj Iron and Steel picked up pace on the second day of the bidding process. The issue was subscribed over 8 times so far, driven by strong interest from retail and non-institutional investors.
Vraj Iron and Steel IPO opens. Should you subscribe to this issue?
Considering the Vraj Iron and Steel IPO, investors can explore the opportunity to invest in a company with manufacturing plants in Chhattisgarh, focusing on Sponge Iron production and various steel products. The IPO presents a chance to be part of a well-established firm with growth prospects and strategic manufacturing facilities.
Medicamen Organics IPO booked 916 times at close; GMP at 147% over issue price
Medicamen Organics IPO, with 315 times subscription, plans to raise Rs 10.5 crore for expansion. The company aims to utilize net proceeds for international market registration and production capacity enhancement, targeting a share premium in the unlisted market.
Shivalic Power Control IPO booked 26x on Day 2. Check GMP and other details
Leading Shivalic Power Control, a technology-driven electric panel manufacturer with a focus on quality and design, we are witnessing strong demand for our IPO shares in the unlisted market, reflecting investor confidence in our company's growth potential.
Visaman Global Sales IPO opens today: Check issue size, price band, GMP and other details
Visaman Global Sales IPO opened today to raise Rs 16.05 crore through a fresh equity issue. The company specializes in steel products and aims to utilize the funds for capital expenditure and working capital needs.
Winny Immigration IPO opens today: Check issue size, price band, GMP and other details
Winny Immigration's SME IPO, aiming to raise Rs 9.13 crore, opened for subscription and will close on June 24 on the NSE SME platform.
IPO Calendar: Ixigo's Rs 740 crore issue, 4 listings on primary market radar next week
The IPO of Le Travenues Technology which operates the travel platform Ixigo is set to launch on June 10, along with Kronox Labs' debut. Analysts foresee a surge in IPO activity in the coming days.
Magenta Lifecare IPO booked over 60x on Day 2; Sattrix Information's issue subscribed 2x
The initial public offering (IPO) of Magenta Lifecare has garnered subscription over 60 times as of Thursday, the second day of the bidding process. The subscription period for this IPO ends on June 7. In contrast, the IPO of Sattrix Information, which opened on the previous day, has received subdued subscription, standing at just over 2 times as of the second day of the bidding process.
Wait for Awfis Space Solutions to deliver stable profitability
The company has an asset-light business model and is debt-free. However, limited operating history, consistent losses, scalability of business, and sustainability of long-term contracts with clients are a few concerns.
Aztec Fluids and Machinery IPO: Check issue size, price band, GMP and other details
Aztec Fluids and Machinery IPO: The company aims to raise about Rs 24 crore through the SME IPO and list the shares on BSE SME platform. Here are 10 key things investors need to know about the public offer before subscribing to the issue.
Premier Roadlines IPO: Check issue size, price band, GMP and other details
Premier Roadlines IPO: The company is targeting to raise approximately Rs 40 crore through the SME IPO and intends to list the shares on the NSE SME platform. Here are 10 essential points investors should familiarize themselves with before considering subscribing to the public offer.
ABS Marine Services IPO: All you need to know before subscribing to the issue
ABS Marine Services IPO: The company is targeting to raise approximately Rs 96.5 crore through the SME IPO and plans to list the shares on the NSE SME platform. Here are 10 important details investors should understand before deciding to subscribe to the public offer.
Piotex Industries IPO: Check issue size, price band, GMP and other details
Piotex Industries IPO: The company intends to raise approximately Rs 14.5 crore through the SME IPO and plans to list the shares on the BSE SME platform. Here are 10 essential aspects investors should be aware of before considering subscription to the issue.
Load More